Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

49.80 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, Jun 12, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	5,480
Open	49.80
Bid (Size)	50.95 (100)
Ask (Size)	51.25 (800)
Prev. Close	49.80
Today's Range	49.80 - 49.80
52wk Range	40.76 - 78.48
Shares Outstanding	78,935,098
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

CRISPR Therapeutics Has $2.4 Billion in Cash and an Approved Drug. Why Is Its Stock Trading Nearly 40% Below the Wall Street Consensus? ↗

June 08, 2026

The company seems to be doing everything it's supposed to be doing; the stock just isn't responding.

Via The Motley Fool

CRISPR Therapeutics Stock Is Absurdly Cheap -- Here's Why Analysts See 437% Upside Potential ↗

June 03, 2026

Its revolutionary CASGEVY treatment could be a sign of what's to come.

Via The Motley Fool

Performance

YTD	-7.4%	-7.4%
1 Month	+2.9%	+2.9%
3 Month	+2.9%	+2.9%
6 Month	-11.5%	-11.5%
1 Year	+19.8%	+19.8%

More News

Eli Lilly Just Proved Gene Editing Could Be Pharma's Next Gold Rush -- but CRISPR Therapeutics Investors Should Watch Out ↗

June 03, 2026

Via The Motley Fool

CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking ↗

June 01, 2026

Via The Motley Fool

CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026? ↗

May 31, 2026

Via The Motley Fool

Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics? ↗

May 25, 2026

Via The Motley Fool

The Best Stocks to Invest $3,000 In Right Now ↗

May 19, 2026

Via The Motley Fool

CRISPR Therapeutics Enters 'Second Phase' as CASGEVY Momentum Builds, Pipeline Data Looms ↗

May 15, 2026

Via MarketBeat

1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist? ↗

May 11, 2026

Via The Motley Fool

Is This Millionaire-Maker Biotech Stock a Buy Right Now? ↗

May 06, 2026

Via The Motley Fool

Want to Build Real Wealth in Healthcare? These Stocks Are Worth Considering ↗

April 30, 2026

Via The Motley Fool

What's the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer. ↗

April 30, 2026

Via The Motley Fool

Should You Forget This High-Yield Pharma Stock and Buy a Growth Name Instead? ↗

April 30, 2026

Via The Motley Fool

3 Growth Stocks That Could Generate 10X Returns ↗

April 29, 2026

Via The Motley Fool

3 Biotech Stocks That Could Benefit from the Patent Cliff ↗

April 27, 2026

Via MarketBeat

CRISPR Therapeutics Has Major Catalysts Ahead. Is This Biotech Stock a Screaming Buy? ↗

April 21, 2026

Via The Motley Fool

2 Billion Reasons to Love CRISPR Therapeutics Right Now ↗

April 13, 2026

Via The Motley Fool

This Biotech Has a Pipeline That Could Redefine Its Entire Therapeutic Area ↗

April 08, 2026

Via The Motley Fool

Is This Biotech Stock Your Best Shot at Building a Millionaire-Making Position? ↗

April 07, 2026

Via The Motley Fool

CRISPR Therapeutics Stock: Is It a Bargain Buy Right Now? ↗

March 23, 2026

Via The Motley Fool

Vertex Pharmaceuticals (VRTX): The Evolution of a Biotech Powerhouse in 2026

March 20, 2026

Via Finterra

Is CRISPR Therapeutics Stock a Buy Now? ↗

March 20, 2026

Via The Motley Fool

3 Monster Stocks to Hold for the Next 10 Years ↗

March 10, 2026

Via The Motley Fool

This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday ↗

March 10, 2026

Via The Motley Fool

Why Is CRSP Stock Falling Pre-Market Today? ↗

March 10, 2026

Via Stocktwits

Frequently Asked Questions

Is CRISPR Therapeutics AG - Common Shares publicly traded?

Yes, CRISPR Therapeutics AG - Common Shares is publicly traded.

What exchange does CRISPR Therapeutics AG - Common Shares trade on?

CRISPR Therapeutics AG - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for CRISPR Therapeutics AG - Common Shares?

The ticker symbol for CRISPR Therapeutics AG - Common Shares is CRSP on the Nasdaq Stock Market

What is the current price of CRISPR Therapeutics AG - Common Shares?

The current price of CRISPR Therapeutics AG - Common Shares is 49.80

When was CRISPR Therapeutics AG - Common Shares last traded?

The last trade of CRISPR Therapeutics AG - Common Shares was at 06/12/26 04:00 PM ET

What is the market capitalization of CRISPR Therapeutics AG - Common Shares?

The market capitalization of CRISPR Therapeutics AG - Common Shares is 3.93B

How many shares of CRISPR Therapeutics AG - Common Shares are outstanding?

CRISPR Therapeutics AG - Common Shares has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.